Pulmonary inflammatory response and immunomodulation to multiple trauma and hemorrhagic shock in pigs.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
28
04
2022
accepted:
31
10
2022
entrez:
8
12
2022
pubmed:
9
12
2022
medline:
15
12
2022
Statut:
epublish
Résumé
Patients suffering from severe trauma experience substantial immunological stress. Lung injury is a known risk factor for the development of posttraumatic complications, but information on the long-term course of the pulmonary inflammatory response and treatment with mild hypothermia are scarce. To investigate the pulmonary inflammatory response to multiple trauma and hemorrhagic shock in a porcine model of combined trauma and to assess the immunomodulatory properties of mild hypothermia. Following induction of trauma (blunt chest trauma, liver laceration, tibia fracture), two degrees of hemorrhagic shock (45 and 50%) over 90 (n = 30) and 120 min. (n = 20) were induced. Animals were randomized to hypothermia (33°C) or normothermia (38°C). We evaluated bronchoalveolar lavage (BAL) fluid and tissue levels of cytokines and investigated changes in microRNA- and gene-expression as well as tissue apoptosis. We observed a significant induction of Interleukin (IL) 1β, IL-6, IL-8, and Cyclooxygenase-2 mRNA in lung tissue. Likewise, an increased IL-6 protein concentration could be detected in BAL-fluid, with a slight decrease of IL-6 protein in animals treated with hypothermia. Lower IL-10 protein levels in normothermia and higher IL-10 protein concentrations in hypothermia accompanied this trend. Tissue apoptosis increased after trauma. However, intervention with hypothermia did not result in a meaningful reduction of pro-inflammatory biomarkers or tissue apoptosis. We observed signs of a time-dependent pulmonary inflammation and apoptosis at the site of severe trauma, and to a lower extent in the trauma-distant lung. Intervention with mild hypothermia had no considerable effect during 48 hours following trauma.
Sections du résumé
BACKGROUND
Patients suffering from severe trauma experience substantial immunological stress. Lung injury is a known risk factor for the development of posttraumatic complications, but information on the long-term course of the pulmonary inflammatory response and treatment with mild hypothermia are scarce.
AIM
To investigate the pulmonary inflammatory response to multiple trauma and hemorrhagic shock in a porcine model of combined trauma and to assess the immunomodulatory properties of mild hypothermia.
METHODS
Following induction of trauma (blunt chest trauma, liver laceration, tibia fracture), two degrees of hemorrhagic shock (45 and 50%) over 90 (n = 30) and 120 min. (n = 20) were induced. Animals were randomized to hypothermia (33°C) or normothermia (38°C). We evaluated bronchoalveolar lavage (BAL) fluid and tissue levels of cytokines and investigated changes in microRNA- and gene-expression as well as tissue apoptosis.
RESULTS
We observed a significant induction of Interleukin (IL) 1β, IL-6, IL-8, and Cyclooxygenase-2 mRNA in lung tissue. Likewise, an increased IL-6 protein concentration could be detected in BAL-fluid, with a slight decrease of IL-6 protein in animals treated with hypothermia. Lower IL-10 protein levels in normothermia and higher IL-10 protein concentrations in hypothermia accompanied this trend. Tissue apoptosis increased after trauma. However, intervention with hypothermia did not result in a meaningful reduction of pro-inflammatory biomarkers or tissue apoptosis.
CONCLUSION
We observed signs of a time-dependent pulmonary inflammation and apoptosis at the site of severe trauma, and to a lower extent in the trauma-distant lung. Intervention with mild hypothermia had no considerable effect during 48 hours following trauma.
Identifiants
pubmed: 36476845
doi: 10.1371/journal.pone.0278766
pii: PONE-D-22-12473
pmc: PMC9728855
doi:
Substances chimiques
Interleukin-10
130068-27-8
Interleukin-6
0
Banques de données
figshare
['10.6084/m9.figshare.21324561.v1']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0278766Informations de copyright
Copyright: © 2022 Oestreich et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Dev Comp Immunol. 2014 Aug;45(2):321-43
pubmed: 24709051
J Trauma Acute Care Surg. 2014 Nov;77(5):780-786
pubmed: 25494433
Eur J Trauma Emerg Surg. 2020 Feb;46(1):31-42
pubmed: 30864051
J Trauma. 2010 May;68(5):1084-98
pubmed: 20453763
Eur J Med Res. 2015 Sep 04;20:73
pubmed: 26338818
Lancet. 2014 Oct 18;384(9952):1455-65
pubmed: 25390327
Nat Immunol. 2018 Apr;19(4):327-341
pubmed: 29507356
Mediators Inflamm. 2015;2015:126060
pubmed: 25694748
Thromb Res. 2011 Nov;128(5):477-82
pubmed: 21492909
J Immunol. 1999 Aug 15;163(4):2217-25
pubmed: 10438964
Nat Commun. 2017 Oct 11;8(1):851
pubmed: 29021573
Methods Mol Biol. 2019;1912:3-32
pubmed: 30635888
Cochrane Database Syst Rev. 2016 Feb 15;2:CD004128
pubmed: 26878327
Dtsch Arztebl Int. 2015 Dec 4;112(49):823-9
pubmed: 26754119
Curr Opin Crit Care. 2014 Oct;20(5):507-15
pubmed: 25010460
Technol Health Care. 2018;26(2):209-221
pubmed: 28968251
Injury. 2013 Jan;44(1):86-90
pubmed: 22040695
J Trauma Acute Care Surg. 2013 Feb;74(2):489-98
pubmed: 23354243
Int J Environ Res Public Health. 2021 Aug 18;18(16):
pubmed: 34444466
J Immunol. 2015 Feb 1;194(3):1239-51
pubmed: 25520401
J Cell Physiol. 2016 Oct;231(10):2097-106
pubmed: 26790856
Microrna. 2014;3(3):174-88
pubmed: 25544471
Ann Transl Med. 2018 Jan;6(2):34
pubmed: 29430451
Stat Med. 1991 Jun;10(6):871-89; discussion 889-90
pubmed: 1831562
J Cereb Blood Flow Metab. 2002 Jan;22(1):21-8
pubmed: 11807390
Eur J Clin Invest. 2018 Dec;48(12):e13026
pubmed: 30215851
PLoS One. 2016 May 04;11(5):e0154788
pubmed: 27144532
Rom J Morphol Embryol. 2016;57(3):951-957
pubmed: 28002510
Acta Anaesthesiol Scand. 2007 Oct;51(9):1211-6
pubmed: 17850561
Am J Respir Crit Care Med. 2011 Nov 1;184(9):1048-54
pubmed: 21816940
World J Emerg Surg. 2017 Sep 2;12:43
pubmed: 28878814
Shock. 2012 Dec;38(6):664-70
pubmed: 23042201
J Immunol. 2012 Mar 1;188(5):2437-44
pubmed: 22287715
Unfallchirurg. 2000 Aug;103(8):632-9
pubmed: 10986906
Sci Rep. 2016 Dec 21;6:39659
pubmed: 28000769
J Trauma Acute Care Surg. 2012 Aug;73(2 Suppl 1):S147-55
pubmed: 22847086
N Engl J Med. 2021 Jun 17;384(24):2283-2294
pubmed: 34133859
Shock. 2013 Oct;40(4):247-73
pubmed: 23856921
Pathol Res Pract. 2010 Mar 15;206(3):145-50
pubmed: 20097014
Cytokine. 2005 Sep 7;31(5):382-93
pubmed: 16099670
Nat Rev Dis Primers. 2021 Apr 29;7(1):30
pubmed: 33927200
Mediators Inflamm. 2012;2012:762840
pubmed: 22481864
Shock. 2015 Feb;43(2):157-65
pubmed: 25347751
Injury. 2005 Jun;36(6):691-709
pubmed: 15910820
Crit Care Med. 2011 Jun;39(6):1359-64
pubmed: 21336107
Shock. 2012 Jun;37(6):605-10
pubmed: 22552021
J Trauma. 2008 Feb;64(2):456-61
pubmed: 18301215
Transl Res. 2011 Apr;157(4):180-90
pubmed: 21420028
J Surg Res. 2012 May 1;174(1):e31-5
pubmed: 22172130
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Shock. 2018 Feb;49(2):164-173
pubmed: 28682946
Front Physiol. 2022 Apr 29;13:901908
pubmed: 35574436
Eur J Trauma Emerg Surg. 2009 Oct;35(5):463-9
pubmed: 26815212
J Interferon Cytokine Res. 2019 Jun;39(6):321-330
pubmed: 30998423
J Trauma Acute Care Surg. 2015 Mar;78(3):516-23
pubmed: 25710421
Crit Care Med. 2014 Feb;42(2):231-42
pubmed: 23989182
Eur J Trauma Emerg Surg. 2016 Feb;42(1):67-75
pubmed: 26038024
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945